- IDEXX Laboratories has directly benefitted from the COVID-19 pandemic as diagnostic testing of animals has increased.
- Share prices and earnings per share have been increasing consistently over the last decade.
- The company may appear to be overpriced now, but strong future growth points to opportunities that shouldn’t be overlooked if bargain prices emerge.
- This article tells what investors could likely make in the future with IDEXX Laboratories and what the real value is versus the current share price.
For further details see:
IDEXX Laboratories And Its Real Value